2026-04-29T19:34:58Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/229582024-11-28T14:43:26Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16939col_20.500.12105_16927col_20.500.12105_16961col_20.500.12105_16962col_20.500.12105_16967col_20.500.12105_16969col_20.500.12105_16971col_20.500.12105_16978col_20.500.12105_16983col_20.500.12105_16986

00925njm 22002777a 4500 dc de Hollanda, Ana author Lecube, Albert author Rubio, Miguel Angel author Sanchez, Enric author Vilarrasa, Nuria author Oliva, Jose Gregorio author Fernandez-Soto, Maria Luisa author Salas-Salvado, Jordi author Ballesteros-Pomar, Maria D. author Ciudin, Andreea author Torres, Ferran author Vidal, Concepcion author Morales, Maria Jose author Valdes, Sergio author Pellitero, Silvia author Minambres, Inka author Masmiquel, Lluis author Goday, Albert author Suarez, Lorena author Flores, Liliam author Bueno, Marta author Caixas, Assumpta author Breton, Irene author Camara, Rosa author Olbeyra, Romina author Penso, Rona author de la Cruz, Maria Jose author Simo-Servat, Andreu author Pereyra-Garcia, Francisca Maria author Lopez-Mezquita, Elena Teresa author Gils, Anna author Fidilio, Enzamaria author Bandres, Orosia author Martinez, Angel author Abuin, Jose author Marques-Pamies, Montserrat author Tuneu, Laura author Arteaga, Magdalena author Castaner, Olga author Goñi, Fernando author Arrizabalaga, Cristina author Antonio Botana, Manuel author Calanas, Alfonso author Rebollo, Angel author 2020-04 Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after bariatric surgery and to evaluate the time-within-remission range as a variable of metabolic control. A descriptive cohort study was done using a computerised multicentre and multidisciplinary registry. All data were adjusted by propensity score. A total of 1186 subjects with a follow-up of 4.5 +/- 2.5 years were included. Type of surgery, diabetes remission, recurrence of diabetes, time-within-remission range and key predictors of diabetes outcomes were assessed. All patients (70% women, 51.4 +/- 9.2 years old, body mass index (BMI) 46.3 +/- 6.9 kg/m(2)) underwent primary bariatric procedures. Time-within-remission range were 83.3% (33.3-91.6) after gastric bypass, 68.7% (7.1-87.5) after sleeve gastrectomy and 90% (83.3-92.8) after malabsorptive techniques (p < 0.001 for all). Duration of diabetes, baseline HbA1c and insulin treatment were significantly negatively correlated with the time-within-remission range. The association of bariatric techniques with time-within-remission range, using gastric bypass as a reference, were: odds ratio (OR) 3.70 (2.34-5.84), p < 0.001 for malabsorptive techniques and OR 0.55 (0.40-0.75), p < 0.001 for sleeve gastrectomy. Characteristics of type 2 diabetes powerfully influence the outcomes of bariatric surgery. The time-within-remission range unveils a superiority of gastric bypass compared to sleeve gastrectomy. De Hollanda A, Lecube A, Rubio MA, Sanchez E, Vilarrasa N, Gregorio Oliva J, et al. New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The Time-Within-Remission Range. J Clin Med. 2020 Apr;9(4):1070. 10.3390/jcm9041070 2077-0383 Journal of Clinical Medicine http://hdl.handle.net/20.500.13003/11165 32283783 L2004142100 2-s2.0-85114061574 https://hdl.handle.net/20.500.12105/22958 531821000177 Bariatric surgery Time-within-remission range Type 2 diabetes Metabolic control New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The Time-Within-Remission Range